Onco-Innovations Balance Sheet

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Cash & Equivalents	0.78	1.11	-	0.02
Cash & Short-Term Investments	0.78	1.11	-	0.02
Cash Growth	-30.21%	-	-	-
Accounts Receivable	0.02	0.05	-	-
Other Receivables	0.04	0.04	-	-
Total Trade Receivables	0.06	0.09	-	-
Other Current Assets	0.41	1.01	-	-
Total Current Assets	1.24	2.22	-	0.02
Total Assets	1.24	2.22	0.45	0.02
Accounts Payable	0.85	0.41	-	-
Total Current Liabilities	0.85	0.41	-	-
Total Liabilities	0.85	0.41	-	-
Common Stock	-	-	-	0
Additional Paid-in Capital	1.8	2.3	-	0.02
Retained Earnings	-	-	-	-0
Total Common Shareholders' Equity	1.8	2.3	-	0.02
Shareholders' Equity	0.39	1.81	-	0.02
Total Liabilities & Equity	1.24	2.22	0.45	0.02
Net Cash (Debt)	0.78	1.11	-0	0.02
Net Cash Growth	-30.21%	-	-	-
Net Cash Per Share	0.01	0.03	-	18517.00
Book Value	1.8	2.3	0	0.02
Book Value Per Share	0.03	0.06	-	18517.00
Tangible Book Value	1.8	2.3	0	0.02
Tangible Book Value Per Share	0.03	0.06	-	18517.00